Facebook Twitter Tumblr Close Skip to main content
A Project of The Annenberg Public Policy Center

Evidence Still Lacking to Support Ivermectin as Treatment for COVID-19

Evidence Still Lacking to Support Ivermectin as Treatment for COVID-19

Randomized controlled trials haven’t found ivermectin is beneficial in treating COVID-19, although results for ongoing studies will provide a more definitive answer. Yet, a video presents two weak studies as “powerful” and “overwhelming” evidence that the medication works to combat COVID-19. 

Benefits of COVID-19 Vaccination Outweigh the Rare Risk of Myocarditis, Even in Young Males

Benefits of COVID-19 Vaccination Outweigh the Rare Risk of Myocarditis, Even in Young Males

Rare cases of myocarditis have been reported following the mRNA COVID-19 vaccines, particularly among young males after a second dose. Most cases resolve quickly without the need for advanced therapies, although research on any potential long-term effects is ongoing. Nonetheless, the benefits of vaccination outweigh the risks in all populations, even in young males.

FactChecking Biden’s Press Conference

FactChecking Biden’s Press Conference

In a nearly two-hour press conference, President Joe Biden stretched the facts and left out important context on vaccinations, funding for lead pipe removal, child poverty and more.

Already Had COVID-19? Vaccines Boost Immunity, Not ‘Wipe Out’ Antibodies

Already Had COVID-19? Vaccines Boost Immunity, Not ‘Wipe Out’ Antibodies

Studies show the COVID-19 vaccines boost the antibody levels and improve the immune response of those who previously had COVID-19. The vaccines do not “wipe out” the antibodies developed by a person who had recovered from the disease, as social media posts have falsely claimed for months.

Ongoing Clinical Trials Will Decide Whether (or Not) Ivermectin Is Safe, Effective for COVID-19

Ongoing Clinical Trials Will Decide Whether (or Not) Ivermectin Is Safe, Effective for COVID-19

Studies on whether ivermectin is beneficial in treating COVID-19 patients haven’t been conclusive, and health officials have warned people not to self-medicate. But multiple large trials are continuing to assess the antiparasitic drug. Yet, Sen. Rand Paul reportedly said researchers were “unwilling to objectively study” it because of “hatred” for Donald Trump. He later acknowledged studies are being done. Here we review the research.